Question 1

What is the purpose of using 68GaNOTA-Anti-HER2 VHH1 in my case?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Repeatability of 68-GaNOTA-Anti-HER2 VHH1 PET/CT in Breast Carcinoma Patients clinical trial (NCT03924466). Contact the study team or your healthcare provider for specific answers.

Question 2

How will this imaging agent help in my treatment plan?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Repeatability of 68-GaNOTA-Anti-HER2 VHH1 PET/CT in Breast Carcinoma Patients clinical trial (NCT03924466). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential risks or side effects of this imaging procedure?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Repeatability of 68-GaNOTA-Anti-HER2 VHH1 PET/CT in Breast Carcinoma Patients clinical trial (NCT03924466). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to come in for scans or injections?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Repeatability of 68-GaNOTA-Anti-HER2 VHH1 PET/CT in Breast Carcinoma Patients clinical trial (NCT03924466). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I do not qualify for this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Repeatability of 68-GaNOTA-Anti-HER2 VHH1 PET/CT in Breast Carcinoma Patients clinical trial (NCT03924466). Contact the study team or your healthcare provider for specific answers.

What this study is about